Novonix (NVNXF) Receivables (2020 - 2025)

Novonix has reported Receivables for 6 years, with the latest figure at $29.8 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables rose 131.83% year-over-year to $29.8 million; the trailing twelve-month figure through Dec 2025 stood at $29.8 million (up 131.83% YoY), and the FY2025 full-year result was $29.8 million, up 131.83% from the prior year.
• Receivables for Q4 2025 stood at $29.8 million, up from $14.1 million in the prior quarter.
• The five-year high for Receivables was $29.8 million in Q4 2025, with the low at $396734.0 in Q2 2023.
• Historically, Receivables has averaged $6.9 million across 5 years, with a median of $2.5 million in 2021.
• Annual changes were most pronounced in 2023 — Receivables sank 86.48% — and 2025, when it soared 1232.26%.
• Novonix's Receivables stood at $2.6 million in 2021, then plunged by 62.97% to $954244.0 in 2022, then surged by 159.14% to $2.5 million in 2023, then jumped by 419.68% to $12.9 million in 2024, then surged by 131.83% to $29.8 million in 2025.
• The last three Receivables figures came in at $29.8 million (Q4 2025), $14.1 million (Q2 2025), and $12.9 million (Q4 2024), per Business Quant data.